Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor ImmunityXian-Yang Li, Mark J. Smyth, Jason Madore et al.|Cancer Discovery|2019Cited by 269
The role of NK cells and CD39 in the immunological control of tumor metastasesHaiyan Zhang, Mark J. Smyth, Dipti Vijayan et al.|OncoImmunology|2019Cited by 87
Control of Metastases via Myeloid CD39 and NK Cell Effector FunctionJuming Yan, Mark J. Smyth, Xian-Yang Li et al.|Cancer Immunology Research|2020Cited by 81